DUCHEMBIO CO, LTD revenue for the last year amounted to 35.10 B KRW, the most of which — 33.28 B KRW — came from its highest performing source at the moment, Radiopharmaceuticals, the year earlier bringing 30.93 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought DUCHEMBIO CO, LTD 34.59 B KRW, and the year before that — 32.39 B KRW.